Average Co-Inventor Count = 4.69
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Intarcia Therapeutics, Inc. (9 from 67 patents)
9 patents:
1. 11246913 - Suspension formulation comprising an insulinotropic peptide
2. 10441528 - Devices, formulations, and methods for delivery of multiple beneficial agents
3. 10363287 - Method of manufacturing an osmotic delivery device
4. 9682127 - Osmotic delivery device comprising an insulinotropic peptide and uses thereof
5. 9572889 - Devices, formulations, and methods for delivery of multiple beneficial agents
6. 8940316 - Osmotic delivery comprising an insulinotropic peptide and uses thereof
7. 8926595 - Devices, formulations, and methods for delivery of multiple beneficial agents
8. 8343140 - Devices, formulations, and methods for delivery of multiple beneficial agents
9. 8299025 - Suspension formulations of insulinotropic peptides and uses thereof